CD274 and colitis: PD-L1-Fc/Oxi-αCD nanoparticles significantly improved colitis symptoms, as manifested by decreased weight loss, reduced DAI scores, and a well-maintained colon length as well as notably reduced levels of proinflammatory cytokines and improved colonic morphology and microstructure.